The BSA‐ORY@TM/cM70 NPs could target tumor cells; after PD‐L1‐mediated endocytosis, ORY‐1001 was released from nanoparticles with the aid of M70 and then replenished intratumoral IFNs and tumor‐infiltrating lymphocytes through LSD inhibition‐induced H3K4me1 and H3K4me2 accumulation; thus, effectively inhibiting xenograft tumor growth, including TNBC, melanoma, and colon cancer.[114]. The gene discussed is CD274; the disease is melanoma.